feisty
How long does surgical menopause last is one of the most searched questions among women facing or recovering from oophorectomy (removal of the ovaries). The short answer: the hormonal state of menopause is permanent once the ovaries are gone, but the acute symptoms that follow surgery are typically most intense in the first six to twelve months and ease considerably with the right management. What makes surgical menopause different from natural menopause isn't the destination. It's the speed of arrival.
What surgical menopause actually is
Natural menopause unfolds over years. Perimenopause gives the body time to adjust as oestrogen drops gradually. Surgical menopause skips that process entirely. When both ovaries are removed, oestrogen production falls to near-zero within 24 hours of surgery. There's no runway, no gradual adjustment period. The hypothalamus registers the drop and responds immediately, which is why hot flushes, night sweats, and sleep disruption can begin within days of the procedure, sometimes before a woman has even left hospital.
Oophorectomy performed alongside a hysterectomy is the most common route to surgical menopause, but it can also follow treatment for ovarian or cervical cancer, endometriosis, or a genetic risk assessment (such as a BRCA mutation). The reason for surgery shapes what treatment options are available afterward, particularly regarding hormone therapy.
Why symptoms tend to be more intense
Doctors consistently report that women who experience surgical menopause have more severe symptoms than women who go through the natural transition. The abruptness is the mechanism. Oestrogen withdrawal that unfolds over a decade in natural menopause happens in days after surgery. The body hasn't had time to adapt, and that gap shows up as more frequent hot flushes, more acute sleep disruption, sharper mood changes, and faster-onset vaginal dryness.
There's also a bone density consideration. Oestrogen protects bone mass. The earlier in life the ovaries are removed, the longer a woman spends without that protection. Women who undergo oophorectomy before the age of 45 face a meaningfully higher risk of osteoporosis and cardiovascular disease compared with women who reach natural menopause at the average age of 51. This is why chemical menopause and surgical menopause both carry management protocols that natural menopause sometimes doesn't demand as urgently.
The first year: what to expect month by month
The first four to eight weeks after surgery are typically the most turbulent. Hot flushes can occur dozens of times a day. Sleep is often badly disrupted. Some women describe the emotional shift as arriving before the physical symptoms, with a sense of flatness or low mood appearing in the first two weeks. Brain fog is common and usually peaks around weeks three to six.
By months three to six, most women on treatment report a significant improvement in vasomotor symptoms (hot flushes and night sweats). Untreated, those symptoms may persist at high intensity throughout the first year and in some cases beyond. Vaginal dryness and changes in libido tend to persist or worsen without direct treatment, because these symptoms are driven by local oestrogen loss rather than systemic fluctuation.
By months six to twelve, women who have started menopausal hormone therapy (MHT) often describe their symptoms as manageable. Women who are not candidates for hormone therapy, or who have chosen not to use it, typically see some natural easing of vasomotor symptoms but continue to manage them actively. The post-menopause symptom picture for surgical menopause can look different from natural menopause because the hormonal floor is often lower.
Does surgical menopause ever end?
The underlying hormonal state doesn't reverse. Without ovaries, oestrogen production remains at post-menopausal levels indefinitely, unless replaced through MHT. What changes over time is the body's response to that hormonal environment. The nervous system adapts. The hypothalamus recalibrates. Symptoms that were severe in the first year often become less disruptive by year two or three, even without treatment changes.
This isn't the same as the menopause being "over." It means the body has adjusted to its new baseline. Women who stop MHT after several years may experience a return of symptoms, particularly hot flushes and sleep disruption, as they go through a second adjustment phase. That phase tends to be milder than the original surgical transition but isn't always trivial.
Treatment options that make a real difference
For women without a contraindication, MHT is the most effective management tool available. It replaces the oestrogen the ovaries can no longer produce and, for women who still have a uterus, includes progestogen to protect the uterine lining. The evidence for MHT started early (before age 45, or within ten years of natural menopause) is strong across bone density, cardiovascular risk, and quality of life measures.
Women who can't use oestrogen-containing therapy, including some breast cancer survivors, have non-hormonal options. These include SSRI and SNRI antidepressants at low doses (effective for hot flushes), gabapentin, and newer neurokinin B receptor antagonists. Cognitive behavioural therapy also has a meaningful evidence base for vasomotor symptoms and mood, and it works without interacting with any existing medications.
Local oestrogen applied directly to the vaginal tissue addresses dryness and urinary symptoms without significant systemic absorption. Many women who can't use systemic hormone therapy can still use local oestrogen safely, though this should always be confirmed with the treating clinician.
Practical considerations most women aren't told upfront
Bone density scanning within the first two years after surgery is worth requesting. Many women who have surgical menopause before 45 don't receive a DEXA scan until they're in their 60s, by which time meaningful bone loss may have already occurred. The same applies to cardiovascular risk review. A lipid panel and blood pressure check in the first year post-surgery is a reasonable baseline to establish.
Sleep disruption in surgical menopause isn't just about hot flushes waking women up. The oestrogen withdrawal itself disrupts sleep architecture. Addressing sleep directly, through consistent timing, temperature control, and if needed a referral for cognitive behavioural therapy for insomnia, tends to produce better outcomes than treating only the flushes.
Libido changes deserve a direct conversation with a clinician. Testosterone plays a role in sexual desire for women, and the ovaries contribute to testosterone production. After oophorectomy, testosterone also drops. Some women find testosterone therapy alongside oestrogen produces a more complete resolution of sexual symptoms than oestrogen alone. This is an area where sex after menopause guidance applies with extra force, because the drop is more abrupt and complete than in natural menopause.
The timeline is manageable, but it requires active management
Surgical menopause doesn't resolve on a fixed schedule. The acute phase lasts six to twelve months. Symptoms ease with appropriate treatment but don't disappear without it. The longer-term considerations, bone density, cardiovascular health, and sexual function, need monitoring beyond the first year. Women who go into the process knowing this tend to advocate more effectively for early treatment and regular follow-up, and that advocacy produces measurably better outcomes.